Incyte has entered into a $750m definitive agreement to acquire Escient Pharmaceuticals and its pipeline of small molecule ...

PME speaks to Lorna Pender, Global Patient Engagement Lead at Clinigen, about the treatment options available to patients ...

Fox&Cat relaunches today with its new people-first, senior consultant operating model and bespoke planning framework, ADAPT ...

If you’ve worked in pharma marketing, you’ll know how hard it can be of late. You’ll spend a load of budget on what looks and ...

Affecting up to one in three people globally in their lifetimes with long-lasting pain and other complications, shingles or ...

Industry is urged to ditch the simple slogans and instead embrace the complexity, as delving more deeply could improve success rates Greek literature is littered with messengers who meet grisly ends ...

Scientists from the Institute of Cancer Research (ICR) and Imperial College London (ICL) have revealed two newly-discovered genes responsible for sensing the environment and adapting cell shape, ...

Roche’s anaplastic lymphoma kinase (ALK) inhibitor Alecensa (alectinib) has been approved by the US Food and Drug Administration (FDA) to treat a subset of early-stage lung cancer patients. The drug ...

Ipsen has announced the opening of a new UK headquarters in London, with the site serving as one of the company’s three global hubs. The Paddington facility is located within a life sciences community ...

Roche has announced positive phase 3 results for its ten-minute subcutaneous (SC) Ocrevus (ocrelizumab) injection in patients ...